PRECIPIO, INC. Net Income (Loss) Attributable to Noncontrolling Interest
PRECIPIO, INC. (PRPO) reported Net Income (Loss) Attributable to Noncontrolling Interest of $25.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2024-03-29
- PRECIPIO, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-12-31 was $7.00K, a 133.33% increase year-over-year.
- PRECIPIO, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-09-30 was $6.00K, a 0.00% change year-over-year.
- PRECIPIO, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-06-30 was $6.00K, a 100.00% increase year-over-year.
- PRECIPIO, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-03-31 was $6.00K, a 500.00% increase year-over-year.
- PRECIPIO, INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $25.00K, a 92.31% increase from fiscal 2021.
- PRECIPIO, INC. net income (loss) attributable to noncontrolling interest for fiscal 2021 was $13.00K, a 51.85% decline from fiscal 2020.
- PRECIPIO, INC. net income (loss) attributable to noncontrolling interest for fiscal 2020 was $27.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $13.00K derived: sum of 2 quarters · filed 2024-03-29 | $19.00K derived: sum of 3 quarters · filed 2024-03-29 | $25.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $6.00K 10-Q · filed 2023-11-13 | $12.00K derived: sum of 2 quarters · filed 2023-11-13 | $18.00K 10-Q · filed 2023-11-13 | $21.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $6.00K 10-Q · filed 2023-08-11 | $12.00K 10-Q · filed 2023-08-11 | $15.00K derived: sum of 3 quarters · filed 2023-08-11 | $21.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $6.00K 10-Q · filed 2023-05-12 | $9.00K derived: sum of 2 quarters · filed 2023-05-12 | $15.00K derived: sum of 3 quarters · filed 2023-05-12 | $18.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $9.00K derived: sum of 2 quarters · filed 2023-03-30 | $12.00K derived: sum of 3 quarters · filed 2023-03-30 | $13.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $6.00K 10-Q · filed 2022-11-10 | $9.00K derived: sum of 2 quarters · filed 2022-11-10 | $10.00K 10-Q · filed 2022-11-10 | $10.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $3.00K 10-Q · filed 2022-08-11 | $4.00K 10-Q · filed 2022-08-11 | $4.00K derived: sum of 3 quarters · filed 2022-08-11 | $14.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-11 | $1.00K derived: sum of 2 quarters · filed 2022-05-11 | $11.00K derived: sum of 3 quarters · filed 2022-05-11 | $28.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $10.00K derived: sum of 2 quarters · filed 2022-03-30 | $27.00K derived: sum of 3 quarters · filed 2022-03-30 | $27.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $10.00K 10-Q · filed 2021-11-12 | $27.00K derived: sum of 2 quarters · filed 2021-11-12 | $27.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $17.00K 10-Q · filed 2021-08-12 | $17.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |